SL-279137

N/A

Report date: 2022/06/17 16:19:11

Base Information

Drug NameSL-279137
Drug Alias NameSL-279137
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion protein
Mechanisms of ActionTumor necrosis factor receptor superfamily member 9 agonistsProgrammed death-ligand 1 blockers
TargetsTumor necrosis factor receptor superfamily member 9Programmed death-ligand 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesShattuck Labs Inc
China Registration ClassN/A

Develop Information

Active CompaniesShattuck Labs Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A